Progress in acute myeloid leukemia treatment – collaborating to develop targeted therapies
How are drug development and clinical trials changing?
What is the focus of lymphoma research in 2017?
Overcoming the challenges of evolving standards of care in CLL: advice for community physicians
What are the predictors of ponatinib treatment response?
Michael J. Mauro